Literature DB >> 17037585

Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN.

Eric C Mossel1, Bruno Sainz, Robert F Garry, C J Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17037585      PMCID： PMC7123288          DOI： 10.1007/978-0-387-33012-9_89

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  16 in total

1.  Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.

Authors:  Carolina Scagnolari; Elisa Vicenzi; Francesca Bellomi; Maria Giuseppina Stillitano; Debora Pinna; Guido Poli; Massimo Clementi; Ferdinando Dianzani; Guido Antonelli
Journal:  Antivir Ther       Date:  2004-12

2.  Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Authors:  Sara Akerström; Mehrdad Mousavi-Jazi; Jonas Klingström; Mikael Leijon; Ake Lundkvist; Ali Mirazimi
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Potentiation of interferon's antiviral activity by the mutually synergistic interaction of MuIFN-alpha/beta and MuIFN-gamma.

Authors:  L A Schwarz; C M Fleischmann; W R Fleischmann
Journal:  J Biol Response Mod       Date:  1984-12

4.  Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus.

Authors:  Marcel Asper; Thomas Sternsdorf; Meike Hass; Christian Drosten; Antje Rhode; Herbert Schmitz; Stephan Günther
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study.

Authors:  Mona R Loutfy; Lawrence M Blatt; Katharine A Siminovitch; Sarah Ward; Bryan Wolff; Hyoung Lho; Dieu H Pham; Hassan Deif; Elizabeth A LaMere; Margaret Chang; Kevin C Kain; Gabriella A Farcas; Patti Ferguson; Mary Latchford; Gary Levy; James W Dennis; Enoch K Y Lai; Eleanor N Fish
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

6.  Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion.

Authors:  M J Sekellick; J W Lowenthal; T E O'Neil; P I Marcus
Journal:  J Interferon Cytokine Res       Date:  1998-06       Impact factor: 2.607

7.  Interferon-beta 1a and SARS coronavirus replication.

Authors:  Lisa E Hensley; Lisa E Fritz; Peter B Jahrling; Christopher L Karp; John W Huggins; Thomas W Geisbert
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

8.  Treatment of SARS with human interferons.

Authors:  J Cinatl; B Morgenstern; G Bauer; P Chandra; H Rabenau; H W Doerr
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

9.  Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

Authors:  Bruno Sainz; Eric C Mossel; C J Peters; Robert F Garry
Journal:  Virology       Date:  2004-11-10       Impact factor: 3.616

10.  The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein.

Authors:  Martin Spiegel; Andreas Pichlmair; Elke Mühlberger; Otto Haller; Friedemann Weber
Journal:  J Clin Virol       Date:  2004-07       Impact factor: 3.168
View more
  7 in total

1.  Nuclear magnetic resonance structure of the N-terminal domain of nonstructural protein 3 from the severe acute respiratory syndrome coronavirus.

Authors:  Pedro Serrano; Margaret A Johnson; Marcius S Almeida; Reto Horst; Torsten Herrmann; Jeremiah S Joseph; Benjamin W Neuman; Vanitha Subramanian; Kumar S Saikatendu; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn; Kurt Wüthrich
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

Review 2.  Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm.

Authors:  Paulina Niedźwiedzka-Rystwej; Adam Majchrzak; Sara Kurkowska; Paulina Małkowska; Olga Sierawska; Rafał Hrynkiewicz; Miłosz Parczewski
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses.

Authors:  Nicole L Messina; Christopher J P Clarke; Ricky W Johnstone
Journal:  JAKSTAT       Date:  2016-05-18

Review 4.  Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.

Authors:  Santhamani Ramasamy; Selvakumar Subbian
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

5.  Antiviral activity of Rheum palmatum methanol extract and chrysophanol against Japanese encephalitis virus.

Authors:  Shu-Jen Chang; Su-Hua Huang; Ying-Ju Lin; Yi-Yun Tsou; Cheng-Wen Lin
Journal:  Arch Pharm Res       Date:  2014-01-07       Impact factor: 4.946

Review 6.  Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID‑19 (Review).

Authors:  José João Name; Andrea Rodrigues Vasconcelos; Ana Carolina Remondi Souza; Wagner José Fávaro
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

Review 7.  Tumor necrosis factor and interferon: cytokines in harmony.

Authors:  Eric Bartee; Mohamed R Mohamed; Grant McFadden
Journal:  Curr Opin Microbiol       Date:  2008-07-01       Impact factor: 7.934
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.